Researchers conducted a cross-sectional study to examine hepatitis B treatment trends among adults in the United States.

Hepatitis B virus (HBV) is a significant public health problem, with over 296 million people chronically infected worldwide. Despite the availability of a safe and effective vaccine for over 40 years, ...

Please provide your email address to receive an email when new articles are posted on . AASLD and IDSA issued new guidance that opens the opportunity for HBV treatment to more people. The new ...

SAN FRANCISCO, Dec. 12, 2025 /PRNewswire/ -- AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a clinical-stage biotechnology company developing oligonucleotide-based ...

"Our findings underscore the critical role of epigenetic mechanisms in HBV pathogenesis. By targeting these pathways, we can develop therapies that not only suppress viral replication but also offer a ...

Particularities of the HBV cycle that favour the development of chronic infection (centre), the clinical challenges stemming from these biological characteristics (top) and the opportunities currently ...

Please provide your email address to receive an email when new articles are posted on . The cumulative probability of functional cure was 14.53% at a mean age of 25.75 years. The annual cure rate was ...

Huahui Health announced that China National Medical Products Administration (NMPA) has granted conditional approval to its Libevitug injection for the treatment of chronic hepatitis D virus infection ...

-- VRON-0200 was safe and well tolerated, with no serious treatment-related adverse events, treatment discontinuations, or treatment-related clinical laboratory abnormalities reported -- In the ...

(Yicai) Jan. 21 -- Chinese innovative pharmaceutical company Kawin Technology plummeted today after withdrawing its ...

A new 10-year regional study reveals that adults living with both HIV and hepatitis B virus across the Asia-Pacific face ...